Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK
This article is commented on by the following:
Stereotactic ablative radiotherapy is an emerging treatment for renal cell carcinoma. Our study objective was to evaluate this therapy in patients with a solitary kidney, focusing on oncologic and renal function outcomes.
Materials and Methods:
We pooled individual patient data from 9 IROCK (International Radiosurgery Oncology Consortium for Kidney) institutions in Germany, Australia, the United States of America, Canada and Japan. Median followup was 2.6 years. Baseline characteristics and outcomes were compared between the solitary and bilateral kidney cohorts. Predictors of renal function after stereotactic ablative radiotherapy were assessed by logistic regression modeling.
A total of 81 patients with a solitary kidney underwent stereotactic ablative radiotherapy. Mean age was 67.3 years and 97.5% of patients had good performance status, including ECOG (Eastern Cooperative Oncology Group) 0-1 or KPS (Karnofsky Performance Status) 70% or greater. Median tumor diameter was 3.7 cm (IQR 2.5–4.3) and 37% of tumors were 4 cm or greater. The 138 patients in the bilateral cohort harbored larger tumors and were older (p <0.001) with a lower baseline estimated glomerular filtration rate (p = 0.024). After stereotactic ablative radiotherapy in the solitary kidney cohort the mean ± SD estimated glomerular filtration rate decrease was –5.8 ± 10.8 ml per minute (–9%). No patient with a solitary kidney required dialysis. After stereotactic ablative radiotherapy a tumor size of 4 cm or greater was associated with an estimated glomerular filtration rate decrease of 15 ml per minute or greater (OR 4.2, p = 0.029). At 2 years the rates of local control, and progression-free, cancer specific and overall survival in the solitary cohort were 98.0%, 77.5%, 98.2% and 81.5%, respectively. There was no significant difference in renal function or oncologic outcomes between the cohorts (p >0.05).
In this analysis of the IROCK database stereotactic ablative radiotherapy in patients with a solitary kidney had an acceptable impact on renal function and achieved excellent oncologic outcomes, similar to those in patients with bilateral kidneys. Thus, stereotactic ablative radiotherapy represents a viable treatment option in patients with renal cell carcinoma in a solitary kidney.
- 1. : Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992-2013. Cancer Epidemiol Biomarkers Prev 2017; 26: 632. Google Scholar
- 2. : Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma. Eur Urol 2000; 37: 521. Google Scholar
- 3. : Cancer Statistics, 2017. CA Cancer J Clin 2017; 67: 7. Google Scholar
- 4. : Renal mass and localized renal cancer: AUA guideline. J Urol 2017; 198: 520. Link, Google Scholar
- 5. : Contemporary clinical epidemiology of renal cell carcinoma: insight from a population based case-control study. J Urol 2010; 184: 2254. Link, Google Scholar
- 6. : Percutaneous ablation versus partial and radical nephrectomy for T1a renal cancer: a population-based analysis. Ann Intern Med 2018; 169: 69. Google Scholar
- 7. : Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors. J Clin Oncol 2002; 20: 2370. Google Scholar
- 8. : Outcomes after cryoablation versus partial nephrectomy for sporadic renal tumors in a solitary kidney: a propensity score analysis. Eur Urol 2018; 73: 254. Google Scholar
- 9. : Functional and oncological outcomes of partial nephrectomy of solitary kidneys. J Urol 2009; 181: 2037. Link, Google Scholar
- 10. : Cryoablation versus minimally invasive partial nephrectomy for small renal masses in the solitary kidney: impact of approach on functional outcomes. J Urol 2013; 189: 818. Link, Google Scholar
- 11. : Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006; 7: 735. Google Scholar
- 12. : End-stage renal disease after renal surgery in patients with normal preoperative kidney function: balancing surgical strategy and individual disorders at baseline. Eur Urol 2016; 70: 558. Google Scholar
- 13. : Strategies for success: a multi-institutional study on robot-assisted partial nephrectomy for complex renal lesions. BJU Int, suppl., 2018; 121: 40. Google Scholar
- 14. : Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach. Nat Rev Urol 2017; 14: 549. Google Scholar
- 15. : Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol 2006; 50: 795. Google Scholar
- 16. : Single fraction radiosurgery for the treatment of renal tumors. J Urol 2015; 193: 771. Link, Google Scholar
- 17. : Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: a report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). Cancer 2018; 124: 934. Google Scholar
- 18. : Consensus statement from the international radiosurgery oncology consortium for kidney for primary renal cell carcinoma. Future Oncol 2016; 12: 637. Google Scholar
- 19. : Below safety limits, every unit of glomerular filtration rate counts: assessing the relationship between renal function and cancer-specific mortality in renal cell carcinoma. Eur Urol 2018; 74: 661. Google Scholar
- 20. : Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. J Urol 2008; 179: 847. Link, Google Scholar
- 21. : Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol 2011; 185: 421. Link, Google Scholar
- 22. : Clinical, pathologic, and functional outcomes after nephron-sparing surgery in patients with a solitary kidney: a multicenter experience. J Endourol 2012; 26: 1361. Google Scholar
- 23. : Tumour in solitary kidney: laparoscopic partial nephrectomy vs laparoscopic cryoablation. BJU Int 2012; 109: 118. Google Scholar
- 24. : Renal function outcomes in patients treated with partial nephrectomy versus percutaneous ablation for renal tumors in a solitary kidney. J Urol 2011; 186: 1786. Link, Google Scholar
- 25. : Minimally invasive nephron sparing management for renal tumors in solitary kidneys. J Urol 2009; 182: 2150. Link, Google Scholar
- 26. : Renal functional outcomes after surgery, ablation, and active surveillance of localized renal tumors: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2017; 12: 1057. Google Scholar
- 27. : Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 2012; 8: 293. Google Scholar
- 28. : Local tumor bed recurrence following partial nephrectomy in patients with small renal masses. J Urol 2018; 199: 393. Link, Google Scholar
- 29. : Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol 2004; 183: 201. Google Scholar
- 30. : Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015; 67: 252. Google Scholar
The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number.
No direct or indirect commercial, personal, academic, political, religious or ethical incentive is associated with publishing this article.